With the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence (mostly caused by HPV) and mortality by 30% by 2030, meaning each country has a target of vaccinating 90% of girls by age 15, 70% of women receiving a high precision...
Cervical cancer vaccine roll-out shows efficacy in reducing cervical cancer and other HPV-related diseaseWith the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence and mortality by 30% by 2030, meaning each country has a target of vaccinating 90% of girls by age 15, 70% of women receiving a high precision screening test at least at age 35 and 45 years of age, and 90% of all...
Average full vaccine coverage is 44% globally, highest in WHO's European region at 60% and lowest in the Americas Region at 31% . Globally including all 194 countries, 21% of girls have received at least one dose of HPV vaccine by age 15, which has steadily increased from 4% in 2010 with a short drop in the COVID years.
The latest prevalence figure for Australia dates to 2019, as they await further data to update to 2023. Since the Australia's 2019 cervical cancer incidence is 6.4 new cases per 100,000 women in 2019, Prof Garland hopes the next update whenever it comes will show Australia has surpassed the target and dropped below four.
Denmark suffered a huge dip in coverage in 2016 with negative mass media crippling coverage which then recovered with various campaigns, while Sweden and Canada have consistently improved vaccine coverage. France has long experienced various issues persuading its population to use vaccines; yet while HPV vaccine coverage is low it is steadily improving.showing how HPV infections, anogenital warts and precancerous cervical lesions all fell substantially following introduction of HPV vaccine.
She also discusses global efforts to boost HPV coverage using a single dose, adopted by 51 countries by March 2024, based on SAGE recommendations from observational and also new RCT data published inshowing one dose effective in those aged 15–20 years, although two doses are still recommended six months apart for those 20 years and over.
Medicine Research Health Research News Health Research Health Science Medicine Science
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
New genetic variants could raise a woman's risk of cervical cancer from HPV infectionsHuman papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
続きを読む »
AACR: At-home HPV testing boosts cervical cancer screening participationMailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening participation in underscreened populations by almost threefold, according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.
続きを読む »
Oncologist suggests three ways to prevent head and neck cancerThroat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: HPV-associated cancers and non-HPV-associated cancers. And depending on the type of subgroup, they are treated differently.
続きを読む »
Researchers identify new genetic risk factors for persistent HPV infectionsHuman papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide.
続きを読む »
Q&A: Does the HPV vaccine protect against cancers and genital warts?Every year in the U.S., human papillomavirus (HPV) causes about 37,000 new cases of cancer. These are cancers that could have been prevented with the HPV vaccine.
続きを読む »
Tributes Pour in for Mum Diagnosed with Terminal Cervical CancerFriends and family remember Cheryl Wood, a mum-of-one who was diagnosed with cervical cancer 10 years ago and recently received a terminal prognosis. She was described as a 'lover of life' and had undergone multiple operations before being given the all-clear. However, her condition worsened in 2022, leading to the discovery of metastatic cervical cancer.
続きを読む »